Where is Intellia headquartered?

Intellia is located in Cambridge, MA.

Who invested in Intellia?

Intellia has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Intellia?

Intellia closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

intelliatx.com

Intellia

Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.

Business Model:

Revenue: $51.4M

Employees: 201-500

Geographic Data

Address: 40 Erie Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$690M

Raised Total:

$775M

Social

Facebook

Twitter

Crunchbase

Metrics

1,082,901Website Global Rank

29,468Website Monthly Traffic

Twitter Followers

Description

Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.

Contact Phone:
+18572856200

Contact Email:

IPO Details

Intellia went public on 5/6/2016 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/6/2016

IPO Valuation:
$772M

Ticker Symbol:
NTLA

IPO Price:
$22/share

Amount Raised:
$108M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised
10/2021	SparingVision	Corporate Round	-
1/2022	Kyverna Therapeutics	Series B	0
1/2022	Kyverna Therapeutics	Series B	0
10/2021	SparingVision	Corporate Round	-

Startup Demographics

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2021	Post-IPO Equity		$690M
11/2014	Series A		$0	Caribou Biosciences Novartis Atlas Venture Novartis Caribou Biosciences Novartis Atlas Venture Novartis
11/2022	Post-IPO Equity		$300M
8/2015	Series B		$70M	OrbiMed HealthCare Fund Management Fidelity Management and Research Company Janus Capital Group Foresite Capital Sectoral Asset Management EcoR1 Capital Atlas Venture Novartis
11/2020	Grant		-
7/2021	Post-IPO Equity		$690M
5/2016	IPO		$108M
9/2015	Series B		$0	Fidelity Management and Research Company Janus Capital Group Sectoral Asset Management EcoR1 Capital Foresite Capital Atlas Venture OrbiMed Novartis OrbiMed Fidelity Management and Research Company Janus Capital Group Sectoral Asset Management EcoR1 Capital Foresite Capital Atlas Venture OrbiMed Novartis OrbiMed
11/2017	Post-IPO Equity		$150M
11/2020	Grant		-	Bill & Melinda Gates Foundation Bill & Melinda Gates Foundation
11/2014	Series A	3	$15M	Atlas Venture Novartis Caribou Biosciences Novartis Atlas Venture Novartis
9/2015	Series B	8	$70M	Fidelity Management and Research Company Janus Capital Group Sectoral Asset Management EcoR1 Capital Foresite Capital Atlas Venture OrbiMed Novartis OrbiMed Fidelity Management and Research Company Janus Capital Group Sectoral Asset Management EcoR1 Capital Foresite Capital Atlas Venture OrbiMed Novartis OrbiMed

Acquisitions

Announced Date	Name	Price
2/2022	Rewrite Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details